News

Medicine pills, white balance 3000K

Vumerity approved for PBS listing for relapsing-remitting MS

Today, the Federal Health and Aged Care Minister announced the listing of Vumerity® (diroximel fumarate) on the Pharmaceutical Benefits Scheme (PBS) for the treatment of Australians living with relapsing remitting MS (RRMS).
pain

Managing MS pain and the mind-body connection

National Pain Week (July 25 to 31) is an annual event coordinated by Chronic Pain Australia. Pain is one of the less recognised symptoms of multiple sclerosis but affects around two-thirds of the over 25,600 Australians living with the disease.
50 Years of Multiple Sclerosis Australia

Is the end in sight? MS research holds great promise

This year marks the 50th year of Multiple Sclerosis Australia, an organisation formed to drive awareness, research, and support for people with multiple sclerosis (MS).
Rohan Greenland The May 50K

From our CEO

As we mark our 50th year, it's deeply encouraging to look at how far we have come over the past five decades and acknowledge the great changes that have taken place to improve the quality of life for people living with MS.
australia-map-with-tasmania-state-highlighted-resize

MS on the rise in Hobart

Epidemiological research shows that MS in the Greater Hobart area is on the rise.
B-cell and antibodies, 3D illustration

Does Epstein Barr virus in early MS bias the immune system towards brain inflammation?

A new study seeks to understand the role of B cells and EBV in the development of MS.
Embryonic stem cell colony

Unravelling the genetics of MS using stem cells

In an attempt to unravel the complex genetics of MS, Australian researchers have generated stem cells from four adult family members with MS.
Kiss Goodbye to MS Tuscany Trek 2022

Pizza + Pasta + Making a difference = The Kiss Goodbye to MS Tuscany Trek 2022

Even if math isn't your strength, you can still combine great food, amazing locations and make a real difference to MS research on the Kiss Goodbye to MS Tuscany Trek 2022. And the good news is, there's still time to sign up!
John Studdy

Honouring a passionate MS advocate: John Studdy

As MS Australia (MSA) celebrates its 50th anniversary, we must acknowledge the hard work and dedication of John Studdy who helped MSA to become what it is today.
Connie The May 50K story

Thank you. You’ve raised over $3.5M for life-changing MS research

May has been a fun-filled month with 19,467 people across Australia getting active to raise money to accelerate research into the prevention, treatments and ultimately a cure for multiple sclerosis.
Rohan Greenland The May 50K

From our CEO

World MS Day – held on May 30 each year – was a memorable one. For me, four events stood out. 
Doctor and patient

You can help progress MS research, even from your home!

The MS Australia Clinical Trials Network is a central point of information for people interested in participating in clinical trials and research studies in MS.
MS organisations to speak with one voice

Too many workplaces failing people with MS but solutions abound

By Associate Professor Des Graham, President, MS Australia - A new workplace and employment survey has provided further evidence that too many Australian workplaces are failing people living with Multiple Sclerosis and other health conditions, and falling well short of community expectations.
Cheryl To stop MS sooner, we need you

To stop MS sooner, we need you

Despite the progress made thanks to MS research, the key to a cure is yet to be found for people like Cheryl. Donations will help fund vital research projects that will build critical knowledge of MS, aiming to prevent and ultimately cure MS.  
Students,Using,Science,Beakers,And,A,Microscope,At,The,Elementary

Predictors of employment after the first episode of demyelination

People with MS face significant employment-related challenges and understanding and preparing for these may improve later employment outcomes.
COVID and immunisation

Response to COVID vaccines in people with MS treated with B cell depleting therapies

A new study confirms that the protective T cell immune response induced by COVID-19 vaccination is preserved in people treated with B cell depleting therapies for MS. This helps our understanding of how vaccinations and MS treatments affect each other.
Parliament House Canberra

MS Australia congratulates the incoming Labor Government

MS Australia, the national peak body for people affected by multiple sclerosis (MS), has today congratulated Prime Minister Anthony Albanese MP and the incoming Labor Government, and reiterated its call for full and ongoing funding of the National Disability Insurance Scheme (NDIS).
Employment & Workplace Survey EDM story

MS Australia launches results of Employment and Workplace Survey

With Monday, May 30 the start of the working week, our focus this World MS Day, is Employment and MS, including its important link to community connection.  

Newsletter subscription

  • Enter your details

Vumerity approved for PBS listing for relapsing-remitting MS